Trial intelligence / Profile preview

Safety of topical glucocorticosteroid after Picato for actinic keratoses

2013-002583-80Phase 4Completed

Sponsor
Department of Dermatology, Bispebjerg Hospital
Start
Sep 2013
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Phase 4, randomised trial in actinic keratosis (AK) comparing Picato alone with Picato plus clobetasol propionate (2 arms). Primary endpoint: Local skin reactions. Started Sep 2013; status: completed.

02

Drugs

ingenol mebutateclobetasol
03

Conditions

actinic keratosis (AK)

Beyond the preview

Go deeper on 2013-002583-80.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-002583-80.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call